References
- 1. Mullen S. Major depressive disorder in children and adolescents. Ment Health Clin. 2018;8:275-283.10.9740/mhc.2018.11.275
- 2. Saragoussi D, Christensen MC, Hammer-Helmich L, Rive B, Touya M, Haro JM. Long-term follow-up on health-related quality of life in major depressive disorder: a 2-year European cohort study. Neuropsychiatr Dis Treat. 2018;14:1339-1350.10.2147/NDT.S159276
- 3. Proudman D, Greenberg P, Nellesen D. The Growing Burden of Major Depressive Disorders (MDD): Implications for Researchers and Policy Makers. Pharmacoeconomics. 2021;39:619-625.10.1007/s40273-021-01040-7
- 4. Evans-Lacko S, Aguilar-Gaxiola S, Al-Hamzawi A, et al. Socio-economic variations in the mental health treatment gap for people with anxiety, mood, and substance use disorders: results from the WHO World Mental Health (WMH) surveys. Psychol Med. 2018;48:1560-1571.10.1017/S0033291717003336
- 5. Richter-Levin G, Xu L. How could stress lead to major depressive disorder? IBRO Rep. 2018;4:38-43.
- 6. WHO. Mental health: strengthening our response! Available at: https://www.who.int/news-room/fact-sheets/detail/mental-health-strengthening-our-response [18 February 2022]
- 7. Cipriani A, Zhou X, Del Giovane C, et al. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Lancet. 2016;388881-90.
- 8. Gao K, Su M, Sweet J, Calabrese JR. Correlation between depression/anxiety symptom severity and quality of life in patients with major depressive disorder or bipolar disorder. J Affect Disord. 2019;244:9-15.10.1016/j.jad.2018.09.063
- 9. Sim K, Lau WK, Sim J, Sum MY, Baldessarini RJ. Prevention of Relapse and Recurrence in Adults with Major Depressive Disorder: Systematic Review and Meta-Analyses of Controlled Trials. Int J Neuropsychopharmacol. 2015;19:pyv076.10.1093/ijnp/pyv076
- 10. Muresan D, Voidăzan S, Salcudean A, Bodo CR, Grecu IG. Bioresonance, an alternative therapy for mild and moderate depression. Exp Ther Med. 2022;23:264.10.3892/etm.2022.11190
- 11. Li H, Luo X, Ke X, et al. Major depressive disorder and suicide risk among adult outpatients at several general hospitals in a Chinese Han population. PLoS One. 2017;12:e0186143.10.1371/journal.pone.0186143
- 12. Malhi GS, Mann JJ. Depression. Lancet. 2018;392:2299-2312.10.1016/S0140-6736(18)31948-2
- 13. Tolentino JC, Schmidt SL. DSM-5 Criteria and Depression Severity: Implications for Clinical Practice. Front Psychiatry. 2018;9:450.10.3389/fpsyt.2018.00450617611930333763
- 14. Rao S, Broadbear J. Borderline personality disorder and depressive disorder. Australasian Psychiatry. 2019;27:573-577.10.1177/103985621987864331573324
- 15. Bjørlykhaug KI, Karlsson B, Hesook SK, Kleppe LC. Social support and recovery from mental health problems: a scoping review. Nordic Social Work Research. 2021:1-32.10.1080/2156857X.2020.1868553
- 16. Choi KW, Kim YK, Jeon HJ. Comorbid Anxiety and Depression: Clinical and Conceptual Consideration and Transdiagnostic Treatment. Adv Exp Med Biol. 2020;1191:219-235.10.1007/978-981-32-9705-0_1432002932
- 17. Ogawa Y, Takeshima N, Hayasaka Y, et al. Antidepressants plus benzodiazepines for adults with major depression. Cochrane Database Syst Rev. 2019;6:CD001026.10.1002/14651858.CD001026.pub2654643931158298
- 18. Lochmann D, Richardson T. Selective Serotonin Reuptake Inhibitors. Handb Exp Pharmacol. 2019;250:135-144.10.1007/164_2018_17230838457
- 19. Dold M, Bartova L, Kautzky A, et al. Psychotic Features in Patients With Major Depressive Disorder: A Report From the European Group for the Study of Resistant Depression. J Clin Psychiatry. 2019;80:17m12090.10.4088/JCP.17m1209030677267
- 20. Salcudean A, Strete EG, Ban RA, Lica MM, Nan AG, Bodo CR. Notions of Ethics and Malpraxis [Noțiuni de etică medicală și malpraxis]. Târgu Mureș: University Press; 2021.
- 21. Staner L. Comorbidity of insomnia and depression. Sleep Med Rev. 2010;14:35-46.10.1016/j.smrv.2009.09.00319939713